Literature DB >> 25755219

Is low dose hydroxyurea the solution to the global epidemic of sickle cell disease?

John J Strouse1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25755219      PMCID： PMC4405448          DOI： 10.1002/pbc.25471

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  10 in total

1.  High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya.

Authors:  Charlotte F McAuley; Clare Webb; Julie Makani; Alexander Macharia; Sophie Uyoga; Daniel H Opi; Carolyne Ndila; Antony Ngatia; John Anthony G Scott; Kevin Marsh; Thomas N Williams
Journal:  Blood       Date:  2010-06-08       Impact factor: 22.113

2.  Hydroxyurea treatment in children with sickle cell anemia in Central America and the Caribbean countries.

Authors:  Eva Svarch; Sergio Machín; Rosa María Nieves; Ana Gladys Mancia de Reyes; Marta Navarrete; Hilze Rodríguez
Journal:  Pediatr Blood Cancer       Date:  2006-07       Impact factor: 3.167

Review 3.  Reproductive issues in sickle cell disease.

Authors:  Kim Smith-Whitley
Journal:  Blood       Date:  2014-12-04       Impact factor: 22.113

4.  The effect of hydroxyurea on compound heterozygotes for sickle cell-hemoglobin D-Punjab--a single centre experience in eastern India.

Authors:  Siris Patel; Prasanta Purohit; Ranjeet Singh Mashon; Snehadhini Dehury; Satyabrata Meher; Sulia Sahoo; Subhransu Sekhar Dash; Kishalaya Das; Padmalaya Das; Dilip Kumar Patel
Journal:  Pediatr Blood Cancer       Date:  2014-02-24       Impact factor: 3.167

5.  Low and fixed dose of hydroxyurea is effective and safe in patients with HbSβ(+) thalassemia with IVS1-5(G→C) mutation.

Authors:  Snehadhini Dehury; Prasanta Purohit; Siris Patel; Satyabrata Meher; Bipin Kishore Kullu; Lulup Kumar Sahoo; Nayan Kumar Patel; Alok Kumar Mohapatra; Kishalaya Das; Dilip Kumar Patel
Journal:  Pediatr Blood Cancer       Date:  2014-12-24       Impact factor: 3.167

6.  The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).

Authors:  Ersi Voskaridou; Dimitrios Christoulas; Antonios Bilalis; Eleni Plata; Konstantinos Varvagiannis; George Stamatopoulos; Klio Sinopoulou; Aggeliki Balassopoulou; Dimitris Loukopoulos; Evangelos Terpos
Journal:  Blood       Date:  2009-11-10       Impact factor: 22.113

7.  Low dose hydroxyurea is effective in reducing the incidence of painful crisis and frequency of blood transfusion in sickle cell anemia patients from eastern India.

Authors:  Dilip K Patel; Ranjeet S Mashon; Siris Patel; Bhabani S Das; Prasanta Purohit; Subasa C Bishwal
Journal:  Hemoglobin       Date:  2012       Impact factor: 0.849

8.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

9.  Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates.

Authors:  Frédéric B Piel; Anand P Patil; Rosalind E Howes; Oscar A Nyangiri; Peter W Gething; Mewahyu Dewi; William H Temperley; Thomas N Williams; David J Weatherall; Simon I Hay
Journal:  Lancet       Date:  2012-10-25       Impact factor: 79.321

10.  Genetic Heterogeneity of Beta Globin Mutations among Asian-Indians and Importance in Genetic Counselling and Diagnosis.

Authors:  Ravindra Kumar; Kritanjali Singh; Inusha Panigrahi; Sarita Agarwal
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-01-02       Impact factor: 2.576
  10 in total
  2 in total

1.  Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan Africa.

Authors:  Patrick T McGann; Thomas N Williams; Peter Olupot-Olupot; George A Tomlinson; Adam Lane; José Luís Reis da Fonseca; Robert Kitenge; George Mochamah; Ham Wabwire; Susan Stuber; Thad A Howard; Kathryn McElhinney; Banu Aygun; Teresa Latham; Brígida Santos; Léon Tshilolo; Russell E Ware
Journal:  Am J Hematol       Date:  2018-01-27       Impact factor: 10.047

2.  KNOWLEDGE, ATTITUDE AND USE OF HYDROXUYREA AMONG ADULT SICKLE CELL DISEASE PATIENTS.

Authors:  O Sonubi; T R Kotila
Journal:  Ann Ib Postgrad Med       Date:  2019-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.